美国FDA药品数据库（U.S. FDA Drugs Database）
符合检索条件的记录共 4 条
共 1 页，当前第 1 页
| 商品名 |
申请号 |
产品号 |
申请类型 |
活性成分 |
剂型/给药途径 |
规格/剂量 |
RLD |
RS |
申请号原始批准/暂定批准日期 |
产品号批准日期 |
申请人 |
市场状态 |
| REZIPRES |
213536 |
001 |
NDA |
EPHEDRINE HYDROCHLORIDE |
SOLUTION;INTRAVENOUS |
23.5MG/5ML (4.7MG/ML) |
Yes
|
No
|
2021/06/14
|
2021/06/14
|
DR REDDYS LABS SA |
Discontinued |
| REZIPRES |
213536 |
002 |
NDA |
EPHEDRINE HYDROCHLORIDE |
SOLUTION;INTRAVENOUS |
47MG/ML (47MG/ML) |
Yes
|
No
|
2021/06/14
|
2021/06/14
|
DR REDDYS LABS SA |
Discontinued |
| REZIPRES |
213536 |
003 |
NDA |
EPHEDRINE HYDROCHLORIDE |
SOLUTION;INTRAVENOUS |
47MG/5ML (9.4MG/ML) |
Yes
|
No
|
2021/06/14
|
2021/06/14
|
DR REDDYS LABS SA |
Discontinued |
| REZIPRES |
213536 |
004 |
NDA |
EPHEDRINE HYDROCHLORIDE |
SOLUTION;INTRAVENOUS |
47MG/10ML (4.7MG/ML) |
Yes
|
Yes
|
2021/06/14
|
2023/12/07
|
DR REDDYS LABS SA |
Prescription |